A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Public ClinicalTrials.gov record NCT07005154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-label, Multi-cohort Study to Assess the Efficacy and Safety of ASP5541 in Participants With Advanced Prostate Cancer
Study identification
- NCT ID
- NCT07005154
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Enrollment
- 218 participants
Conditions and interventions
Conditions
Interventions
- ASP5541 Drug
- Adrenocorticotropic hormone Drug
- Prednisolone Drug
- Prednisone Drug
- abiraterone acetate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2025
- Primary completion
- May 30, 2032
- Completion
- May 30, 2032
- Last update posted
- Apr 30, 2026
2025 – 2032
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clearview Cancer Institute | Huntsville | Alabama | 35805 | Recruiting |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | Recruiting |
| Associated Urological Specialists | Chicago Ridge | Illinois | 60415 | Recruiting |
| Ochsner Health - Ochsner Medical Center - New Orleans | New Orleans | Louisiana | 70121 | Recruiting |
| New Mexico Oncology Hematology Consultants | Albuquerque | New Mexico | 87109 | Recruiting |
| Solaris Health - The Urology Group | Cincinnati | Ohio | 45212 | Recruiting |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | Recruiting |
| Tennessee Oncology Nashville | Nashville | Tennessee | 37203 | Recruiting |
| University of Virginia Cancer Center | Charlottesville | Virginia | 22908-07 | Recruiting |
| UW Health Carbone Cancer Center | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07005154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07005154 live on ClinicalTrials.gov.